Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
BPC-157 research has extensively documented mucosal healing and cytoprotection [7], while KPV studies demonstrated significant reduction of colitis severity in multiple rodent models[8]: BPC-157 component: Healing acceleration in NSAID-induced gastric ulcers and stress-induced damage KPV component: Reduced inflammatory cell infiltration and lower MPO activity in DSS-induced colitis Combined potential: Addresses both tissue damage and inflammatory pathways simultaneously Fistula healing demonstrated in BPC-157 studies with potential inflammatory control from KPV PepT1-mediated KPV uptake enables targeted delivery to inflamed intestinal tissues Research on individual components suggests the combination may provide superior outcomes by healing damaged tissue while actively suppressing inflammatory cascades that impair repair[9]
L-Carnitine converts fat cells into energy by transporting fatty acids into the mitochondria
REDEFINE 1 (combination, no diabetes) The landmark trial
Canadian Regulatory Context BPC-157 is not approved by Health Canada for human therapeutic use
US$ 23.39
US$ 25.34
US$ 22.52
US$ 28.25
